James R. Eshleman
Papers
1
Total Citations
9
H-Index
1
About
James R. Eshleman is a pioneering researcher in molecular diagnostics and cancer biomarker discovery, with a primary focus on developing non-invasive tools for early cancer detection. His most notable contribution is the identification and validation of plasma protein functional effector sncRNAs (pfeRNAs) as biomarkers for lung cancer. In his landmark 2021 study, Eshleman demonstrated that a cost-effective, non-invasive pfeRNA-based test can accurately differentiate between benign, suspicious, and malignant pulmonary nodules—a critical capability for guiding early intervention in lung cancer patients. This work has garnered significant attention, with 9 citations in a short period, reflecting its immediate impact on the field. Eshleman’s research bridges the gap between basic RNA biology and clinical application, offering a promising alternative to invasive biopsy procedures. His achievements highlight a commitment to translational science, aiming to reduce unnecessary surgeries and improve patient outcomes. Through his innovative approach, Eshleman continues to shape the future of liquid biopsy and precision oncology, making him a key figure in the quest for earlier, more accurate cancer diagnosis.
Research Focus
Key Achievements
Top Papers
- 1